FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982160989> ?p ?o ?g. }

• W1982160989 endingPage "144" @default.
• W1982160989 startingPage "131" @default.
• W1982160989 abstract "The transforming growth factor-beta (TGF-β) signaling pathway is known to play a critical role in promoting tumor growth. Consequently, blocking this pathway has been found to inhibit tumor growth. In order to achieve an optimal anti-tumor effect, however, it remains to be established whether blocking the TGF-β signaling pathway alone is sufficient, or whether the tumor microenvironment plays an additional, possibly synergistic, role. To investigate the relevance of blocking TGF-β signaling in tumor cells within the context of their respective tissue microenvironments, we treated a panel of patient-derived xenografts (PDX) with the selective TGF-β receptor kinase inhibitor LY2157299 monohydrate (galunisertib) and assessed both the in vitro and in vivo effects. Galunisertib was found to inhibit the growth in an in vitro clonogenic assay in 6.3 % (5/79) of the examined PDX. Evaluation of the expression profiles of a number of genes, representing both canonical and non-canonical TGF-β signaling pathways, revealed that most PDX exhibited expression changes affecting TGF-β downstream signaling. Next, we subjected 13 of the PDX to an in vivo assessment and, by doing so, observed distinct response patterns. These results suggest that, next to intrinsic, also extrinsic or microenvironmental factors can affect galunisertib response. pSMAD2 protein expression and TGF-βRI mRNA expression levels were found to correlate with the in vivo galunisertib effects. From our data we conclude that intrinsic, tumor-dependent TGF-β signaling does not fully explain the anti-tumor effect of galunisertib. Hence, in vivo xenograft models may be more appropriate than in vitro clonogenic assays to assess the anti-tumor activity of TGF-β inhibitors such as galunisertib." @default.
• W1982160989 created "2016-06-24" @default.
• W1982160989 creator A5003838655 @default.
• W1982160989 creator A5028752254 @default.
• W1982160989 creator A5033549340 @default.
• W1982160989 creator A5039861417 @default.
• W1982160989 date "2015-01-09" @default.
• W1982160989 modified "2023-10-10" @default.
• W1982160989 title "Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts" @default.
• W1982160989 cites W1965188536 @default.
• W1982160989 cites W1974203539 @default.
• W1982160989 cites W1986304685 @default.
• W1982160989 cites W2002697796 @default.
• W1982160989 cites W2005983388 @default.
• W1982160989 cites W2009474269 @default.
• W1982160989 cites W2013012202 @default.
• W1982160989 cites W2019835040 @default.
• W1982160989 cites W2026901935 @default.
• W1982160989 cites W2035653659 @default.
• W1982160989 cites W2046673025 @default.
• W1982160989 cites W2054034979 @default.
• W1982160989 cites W2064852464 @default.
• W1982160989 cites W2070269722 @default.
• W1982160989 cites W2072656923 @default.
• W1982160989 cites W2073473087 @default.
• W1982160989 cites W2083802683 @default.
• W1982160989 cites W2087312216 @default.
• W1982160989 cites W2101318220 @default.
• W1982160989 cites W2117225762 @default.
• W1982160989 cites W2132577395 @default.
• W1982160989 cites W2138055263 @default.
• W1982160989 cites W2140740750 @default.
• W1982160989 cites W2142769937 @default.
• W1982160989 cites W2148543405 @default.
• W1982160989 cites W2150548551 @default.
• W1982160989 cites W2153602090 @default.
• W1982160989 cites W2155208683 @default.
• W1982160989 cites W2158155247 @default.
• W1982160989 cites W2162371443 @default.
• W1982160989 cites W2163797065 @default.
• W1982160989 cites W2171940229 @default.
• W1982160989 cites W2262734805 @default.
• W1982160989 cites W2340314366 @default.
• W1982160989 cites W2398401644 @default.
• W1982160989 cites W2424848979 @default.
• W1982160989 cites W2597282070 @default.
• W1982160989 cites W2951164008 @default.
• W1982160989 cites W4253186968 @default.
• W1982160989 cites W54649336 @default.
• W1982160989 doi "https://doi.org/10.1007/s13402-014-0210-8" @default.
• W1982160989 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4412926" @default.
• W1982160989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25573078" @default.
• W1982160989 hasPublicationYear "2015" @default.
• W1982160989 type Work @default.
• W1982160989 sameAs 1982160989 @default.
• W1982160989 citedByCount "31" @default.
• W1982160989 countsByYear W19821609892015 @default.
• W1982160989 countsByYear W19821609892016 @default.
• W1982160989 countsByYear W19821609892017 @default.
• W1982160989 countsByYear W19821609892018 @default.
• W1982160989 countsByYear W19821609892019 @default.
• W1982160989 countsByYear W19821609892020 @default.
• W1982160989 countsByYear W19821609892021 @default.
• W1982160989 countsByYear W19821609892023 @default.
• W1982160989 crossrefType "journal-article" @default.
• W1982160989 hasAuthorship W1982160989A5003838655 @default.
• W1982160989 hasAuthorship W1982160989A5028752254 @default.
• W1982160989 hasAuthorship W1982160989A5033549340 @default.
• W1982160989 hasAuthorship W1982160989A5039861417 @default.
• W1982160989 hasBestOaLocation W19821609891 @default.
• W1982160989 hasConcept C117262875 @default.
• W1982160989 hasConcept C118131993 @default.
• W1982160989 hasConcept C128240485 @default.
• W1982160989 hasConcept C151730666 @default.
• W1982160989 hasConcept C170493617 @default.
• W1982160989 hasConcept C184235292 @default.
• W1982160989 hasConcept C185592680 @default.
• W1982160989 hasConcept C202751555 @default.
• W1982160989 hasConcept C207001950 @default.
• W1982160989 hasConcept C2776107976 @default.
• W1982160989 hasConcept C2778229498 @default.
• W1982160989 hasConcept C2779343474 @default.
• W1982160989 hasConcept C3020616263 @default.
• W1982160989 hasConcept C502942594 @default.
• W1982160989 hasConcept C54355233 @default.
• W1982160989 hasConcept C55493867 @default.
• W1982160989 hasConcept C62478195 @default.
• W1982160989 hasConcept C86803240 @default.
• W1982160989 hasConcept C95444343 @default.
• W1982160989 hasConceptScore W1982160989C117262875 @default.
• W1982160989 hasConceptScore W1982160989C118131993 @default.
• W1982160989 hasConceptScore W1982160989C128240485 @default.
• W1982160989 hasConceptScore W1982160989C151730666 @default.
• W1982160989 hasConceptScore W1982160989C170493617 @default.
• W1982160989 hasConceptScore W1982160989C184235292 @default.
• W1982160989 hasConceptScore W1982160989C185592680 @default.
• W1982160989 hasConceptScore W1982160989C202751555 @default.
• W1982160989 hasConceptScore W1982160989C207001950 @default.

• next